Пошуковий запит: (<.>A=Lukyanova N$<.>) |
Загальна кількість знайдених документів : 18
Представлено документи з 1 до 18
|
| 1. | Ж14160 Lukyanova N. Y. Expression of p53 and Bcl-2 Proteins in Epithelial Ovarian Carcinoma With Different Grade of Differentiation [Текст] 22: 1-2 // Эксперим. онкология.-С.91-93
|
| 2. | Ж14160 Chekhun V. F. The role of expression of the components of proteome in the formation of molecular profile of human ovarian carcinoma A2780 cells sensitive and resistant to cisplatin [Текст] 27: 3 // Эксперим. онкология.-С.191-195
|
| 3. | Ж14160/прил. Bereznaya N. M. Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors [Текст] 30: 4 // Онкология.-С.295-299
|
| 4. | Ж14160/прил. Kudryavets Yu. I. Modifying influence of prolonged action of interferon on phenotypic characteristics of human lung cancer cells in vitro [Текст] 30: 4 // Онкология.-С.283-288
|
| 5. | Ж14160 Bazas V. M. Relation between cell-to-cell adhesion and angiogenesis and clinico-morphological prognostic factors in patients with gastric cancer [Текст] 30: 3 // Эксперим. онкология.-С.235-239
|
| 6. | Ж14160 Chekhun V. F. Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients [Текст] 31: 2 // Эксперим. онкология.-С.123-124
|
| 7. | Ж14160 Lukyanova N. Yu. Molecular profile and cell cycle in MCF-7 cells resistant to cisplatin and doxorubicin [Текст] 31: 2 // Эксперим. онкология.-С.87-91
|
| 8. | Ж21341/а Rusetskaya N. Cell cycle differences between sensitive MCF-7 cells and MCF-7/DOX and MCF-7/DDP cells with doxorubicin and cisplatin resistance phenotype [] // Український біохімічний журнал, 2009. т.Т. 81,N № 4 (спец. вип.).-С.246
|
| 9. | Ж14160/прил. Shepil O. V. A study of transferrin and ferritin expression in tumor cells of patients with breast cancer [] // Онкология, 2014. т.Т. 16,N № 2.-С.108-112
|
| 10. | Ж21341/а Chekhun V. F. Remodulating effect of doxorubicin on the state of iron-containing proteins, and redox characteristics of tumor with allowance for its sensitivity to cytostatic agents [] // The Ukrainian Biochemical Journal, 2016. т.Т. 88,N № 1.-С.99-108
|
| 11. | Ж14160 Tkalia I. G. Clinical significance of hormonal receptor status of malignant ovarian tumors [] // Экспериментальная онкология, 2014. т.Т. 36,N № 2.-С.125-133
|
| 12. | Ж14160 Chekhun S. V. Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells [] // Экспериментальная онкология, 2014. т.Т. 36,N № 3.-С.179-183
|
| 13. | Ж14160 Tkalia I. G. Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor [] // Экспериментальная онкология, 2014. т.Т. 36,N № 3.-С.184-190
|
| 14. | Ж14160 Chekhun V. F. Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin [] // Экспериментальная онкология, 2014. т.Т. 36,N № 3.-С.196-201
|
| 15. | Ж14160 Rieznichenko L. S. Gold nanoparticles synthesis and biological activity estimation in vitro and in vivo [] // Экспериментальная онкология, 2012. т.Т. 34,N № 1.-С.25-28
|
| 16. | Ж14160 Todor I. N. The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells [] // Экспериментальная онкология, 2012. т.Т. 34,N № 2.-С.97-100
|
| 17. | Ж100480 Petranovska A. L. Magnetically sensitive nanocomposites and magnetic liquids based on magnetite, gemcitabine, and antibody HER2 [] // Хімія, фізика та технологія поверхні, 2019. т.Т. 10,N № 4.-С.419-431
|
| 18. | Ж100480 Petranovska A. L. Antitumor vector systems based on bioactive lectin of Bacillus subtilis IMB B-7724 [] / A. L. Petranovska, A. P. Kusyak [et al.] // Хімія, фізика та технологія поверхні, 2021. т.Т. 12,N № 3.-С.190-200
|
Простий пошук
Віртуальна довідка